Bush proves hot property for BioMed Realty in its Cambridge2Cambridge drive
He will lead the operations and facilities functions across two core markets – Boston-Cambridge, MA, and Cambridge, UK. Bush will be based at the company’s office in Cambridge, MA, while reporting to Colleen O’Connor, BioMed Realty’s Executive Vice President, Market Lead, East Coast & UK Markets.
Colleen O’Connor said: “We are excited to welcome Mark to BioMed Realty, where he brings his leadership, passion and expertise to our team in serving our tenants and their experience.”
“Mark’s extensive experience in the commercial real estate industry will be a valuable asset, strengthening our efforts and contributing to BioMed Realty’s success in providing life science and technology companies with differentiated real estate solutions.”
Bush added: “I am thrilled to join this exceptionally talented team at BioMed Realty, a company that I have long admired. “It’s an honour to work alongside them as they continue to support their current and future tenants, which include some of the world’s most innovative life science and technology companies.”
Bush most recently served as Senior Vice President, Asset Management at The Davis Companies, where he provided strategic oversight and direction for a portfolio of commercial real estate properties.
He brings over 20 years of leadership experience in operations and asset management within the commercial real estate industry to BioMed Realty.
Prior to joining The Davis Companies in 2015, Bush was Vice President, Asset Management, at AEW Capital Management, after holding positions with Brixmor Property Group and Fidelity Investments.
Founded in 2004, BioMed Realty has grown significantly and is now the largest private operator of life science real estate, with a portfolio valued at more than $22 billion.
It operates 16 million square feet of life science infrastructure within core innovation hubs in the United States and the United Kingdom, including Boston/Cambridge, San Francisco, San Diego, Seattle, Boulder and Cambridge, UK. BioMed Realty entered the UK life science real estate market via the acquisition of the 120-acre Granta Park campus in Cambridge in 2012.
It also launched BioMed@Babraham in 2017 – a 99,000 sq ft life science facility at the Babraham Research Campus. The facility is home to Mission Therapeutics, bit.bio and RxCelerate.